ISTH 2022 Congress

Diagnostics and OMICs » Cellular Therapies

Theme Navigation

ISTH 2022 Congress
- Diagnostics and OMICs
  - Cellular Therapies

Abstract Number: PB0155

A potential use of leukocyte-platelet rich fibrin secretome to improve wound healing and bone regeneration

L. Hermida-Nogueira¹, J. Blanco², J. Reseland³, Á. García¹

Abstract Number: PB0156

Expression of Exogenous Proteins in Donor Platelets Treated with Lipid Nanoparticles Encapsulating mRNA

J. Leung¹, C. Strong², K. Badior³, M. Robertson⁴, L. Juang⁴, E. Jan⁴, D. Devine⁴, P. Cullis⁴, C. Kastrup⁵

Abstract Number: PB0154

Lyophilized human platelets are superior to apheresis or fresh-drawn platelets in their ability to accelerate thrombin production

L. Booth¹, M. Dickerson², K. Moskowitz¹

Abstract Number: PB0157

Platelets genetically modified with mRNA-lipid nanoparticles are functionally similar to clinically transfused platelets in vitro

C. Strong¹, J. Leung², K. Badior³, M. Robertson⁴, E. Jan⁴, P. Cullis⁴, D. Devine⁴, C. Kastrup⁵

« View all themes from the ISTH 2022 Congress